Abstract
Purpose To demonstrate the value of “smoothness index” as a novel tool for quantitative analysis of iris surface findings in unilateral Fuchs’ uveitis (FU).
Methods In this observational study, both phakic eyes from patients with the diagnosis of unilateral FU were enrolled. All eyes underwent a complete ophthalmic examination and anterior segment optical coherence tomography(AS-OCT). The images were extracted and exported to the ImageJ software for calculating the “smoothness index (SI)”. The SI was defined as ratio of length of the straight line connecting the most peripheral and the most central points of anterior iris surface to actual length of this boundary.
Results Forty eyes from 20 patients with unilateral FU were enrolled. Mean age of patients was 40±10 years. Mean overall SI was 0.876± 0.030 in eyes with FU that was significantly more than fellow control eyes (0.841± 0.041). (p=0.005) The mean temporal and nasal SI were 0.878± 0.035 and 0.874± 0.033 in eyes with FU, compared to 0.843± 0.041 and 0.838± 0.047 in control fellow eyes, respectively. (p = 0.008 and p = 0.009, respectively)
Conclusion Iris “smoothness index” is a novel index to quantitatively document diffuse smoothness of iris anterior surface in eyes with FU. This index may facilitate diagnosis of subtle iris atrophic changes in these eyes, especially when heterochromia is absent.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
no funding was received
Author Declarations
All relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.
Yes
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Declarations:
Financial Support: None
Conflict of interest: None of the authors have any proprietary interests or conflicts of interest related to this submission.
Availability of data and material: The data generated during or/and analysed during the current study are available from the corresponding author.
Code availability: Not applicable
Acknowledgements: The authors would like to thank Azar Rezaei, Maryam Kasiri and Nastaran Salimi for their kind contribution to this study.
Data Availability
The data generated during or/and analysed during the current study are available from the corresponding author
